The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF

Europace. 2015 Jun;17(6):864-70. doi: 10.1093/europace/euv032.

Abstract

Aims: To describe the long-term patterns of atrial fibrillation (AF) in patients with permanent pacemakers.

Methods and results: A total of 2092 pacemaker Holter downloads were analysed in 323 patients with dual chamber permanent pacemakers, describing a cumulative 1031 patient-years of beat-to-beat monitoring. Four subtypes of AF were applied: (i) non-progressive low-burden PAF (NPLB-PAF, n = 120): such patients never have >1% AF burden throughout follow-up; (ii) chronic progressive PAF (CP-PAF, n = 55): AF burden increases but is never 100%; (iii) relapsing-remitting PAF (RR-PAF, n = 78): AF burden has reduced at least once by more than 2% and is never 100%; (iv) persistent AF (PersAF, n = 70): 100% AF burden for at least 28 days. Overall, mean AF burden rose 0.34% per year (P < 0.0001). After accounting for age, heart failure (HF) had a significant interaction with AF burden (P = 0.0022), but HATCH score and CVA/TIA did not. There were no differences in the frequency or duration of monitoring between the four AF subtypes. Atrial fibrillation episode frequency discriminated between subtypes (P = 0.0004). Eighteen of 70 (26%) patients with PersAF had pacemaker documented episodes of sinus rhythm (i.e. reversion to 'paroxysmal AF') after the onset of PersAF.

Conclusion: In this cohort, the development of AF over time appears more complex than current definitions suggest. Atrial fibrillation can remain low burden without progression, remit-relapse, or progress as is described in currently accepted definitions. More frequent episodes of AF indicated a favourable subtype. Persistent AF is not inevitable, and can revert to paroxysmal AF.

Clinical trial registration: NCT02016950, http://clinicaltrials.gov/show/NCT02016950.

Keywords: Atrial fibrillation; Permanent pacemaker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Aged
  • Atrial Fibrillation / epidemiology
  • Atrial Fibrillation / physiopathology*
  • Atrioventricular Block / epidemiology
  • Atrioventricular Block / therapy*
  • Cohort Studies
  • Disease Progression
  • Electrocardiography, Ambulatory*
  • Female
  • Heart Failure / epidemiology
  • Humans
  • Ischemic Attack, Transient / epidemiology
  • Male
  • Multivariate Analysis
  • Pacemaker, Artificial*
  • Retrospective Studies
  • Sick Sinus Syndrome / epidemiology
  • Sick Sinus Syndrome / therapy*
  • Stroke / epidemiology

Associated data

  • ClinicalTrials.gov/NCT02016950